
ScitoVation, a biotech firm, leverages science and technology to enhance human health through safer pharmaceuticals and food ingredients.
ScitoVation, founded with a mission to enhance human health through scientific and technological advancements, is a biotechnology company that specializes in understanding the effects of chemical compounds and drugs. The firm offers services that include safety and efficacy assessments of pharmaceuticals, chemicals, food ingredients, and cosmetics. Utilizing New Approach Methods (NAMs), ScitoVation aims to help clients develop safer and more effective products in a faster and more efficient manner.
Notable figures affiliated with ScitoVation include Dr. Paul White, known for his expertise in quantitative interpretation of genotoxicity dose-response data. The company has garnered recognition for its successful partnerships and flexibility in addressing client needs. ScitoVation's impact is evident in its contributions to global health, providing critical insights that aid in the development of safer consumer products and pharmaceuticals.

Scienture
scienture.com

Agile Sciences
agilesci.com

SciKon Innovation

Insightful Science

Know Bio
knowbiollc.com

Scitara
scitara.com

Scinet
scinet.one

Discovery Innovations

Viscient Bio

BioAnalytics

Parimer Scientific
parimer.com

BiotechInnova
biotechinnova.com

ABio-X
abio-x.com

SciTech Development
scitechsdp.com

Inotiv
inotivco.com
Companies similar to ScitoVation include Scienture, Agile Sciences, SciKon Innovation and Insightful Science.
ScitoVation was founded in 2016.
ScitoVation's headquarters is located in Durham, NC, US.
ScitoVation's most recent funding round was for $270k (USD) in July 2023.
As of Jul 11, 2023, ScitoVation has raised a total of $360k (USD).
ScitoVation has 24 employees as of Feb 5, 2024.